Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/24/2008 | US20080178354 Chimeric isoprenoid synthases and uses thereof |
07/24/2008 | US20080178353 Introducing into cell a recombinant expression cassette comprising polynucleotide which functions as development regulator; enhanced growth, improved strength |
07/24/2008 | US20080178352 Which direct localization of polynucleotides; nucleic acid of given sequence that hybridizes with probe; modifies photosynthesis and synthesis of fatty acids, amino acids, oils, carotenoids and starch |
07/24/2008 | US20080178351 Which direct localization of polynucleotides; nucleic acid of given sequence that hybridizes with probe; modifies photosynthesis and synthesis of fatty acids, amino acids, oils, carotenoids and starch |
07/24/2008 | US20080178350 Soybean variety 92m22 |
07/24/2008 | US20080178349 Methods for modulating apical bud development in a plant |
07/24/2008 | US20080178348 Homologous recombination mediated transgene deletion in plant cells |
07/24/2008 | US20080178347 Polynucleotide encoding polypeptide having aspartate kinase activity; transforming cell for development of nutritionally improved crop plants |
07/24/2008 | US20080178346 Use of a gene encoding a histidine protein kinase to create drought resistant plants |
07/24/2008 | US20080178325 Genetic Markers For Orobanche Resistance in Sunflower |
07/24/2008 | US20080178324 Lettuce Cultivar 12-0402033-B |
07/24/2008 | US20080178323 Expression vector comprising nucleotide sequences coding bacillus endotoxin for use in transformation and generation of insect resistant plants |
07/24/2008 | US20080178322 Soybean variety 4174206 |
07/24/2008 | US20080178321 Soybean variety 4305498 |
07/24/2008 | US20080178320 Soybean variety d0064801 |
07/24/2008 | US20080178319 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced carbohydrate and fatty acid metabolism; improved fiber quality |
07/24/2008 | US20080178318 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced carbohydrate and fatty acid metabolism; improved fiber quality |
07/24/2008 | US20080178317 Soybean variety 4835953 |
07/24/2008 | US20080178316 Soybean Cultivar 1335025 |
07/24/2008 | US20080178315 Soybean Cultivar 1686017 |
07/24/2008 | US20080178314 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced carbohydrate and fatty acid metabolism; improved fiber quality |
07/24/2008 | US20080178313 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced carbohydrate and fatty acid metabolism; improved fiber quality |
07/24/2008 | US20080178311 Using vector transformation and direct testis injection as gene delivery tool; human protein expression in non-human mammals |
07/24/2008 | US20080178310 Transgenic fish comprising myostatin insertional disruption for use in production of progeny with increased muscle mass and reduced cholesterol concentrations |
07/24/2008 | US20080178309 Fluorescent Indicators of Hydrogen Peroxide and Methods for Using Same |
07/24/2008 | US20080178308 Immunoglobulin specific to prostate tumor associated protein (24P4C12) for use in diagnosis, prevention and treatment of cell proliferative disorders |
07/24/2008 | US20080178307 Compositions, organisms and methodologies employing a novel human protein phosphatase |
07/24/2008 | US20080177479 Describing and storing method of alignment information |
07/24/2008 | US20080177053 DNA nanocage by self-organization of DNA and process for producing the same, and DNA nanotube and molecule carrier using the same |
07/24/2008 | US20080177046 Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with Her-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes |
07/24/2008 | US20080177044 Novel saitohin gene and uses of same |
07/24/2008 | US20080177042 Leucine-based motif and clostridial neurotoxins |
07/24/2008 | US20080177041 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
07/24/2008 | US20080177039 Lymphocyte regulatory polypeptide for enhancing immunological response to infection |
07/24/2008 | US20080177037 Leucine-based motif and clostridial neurotoxins |
07/24/2008 | US20080177030 Using fos oncogene to identify modulator which prevent transcription factor complex formation; antitumor agents; viricides |
07/24/2008 | US20080176961 Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain |
07/24/2008 | US20080176959 Biodegradable polyphosphates complex for controlled release of bioactive substances and related methods |
07/24/2008 | US20080176944 Elongase Genes and Uses Thereof |
07/24/2008 | US20080176814 nonpeptidic inhibitors of cathepsin G; genetic diseases, degenerative diseases, DNA damages, neoplasia and/or skin diseases; DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing |
07/24/2008 | US20080176812 Allele-specific silencing of disease genes |
07/24/2008 | US20080176803 or Nicastrin complex with the novel protein Sambiasin; drugs screening, drug targets, diagnosis or prognosis of Alzheimer's disease; neurodegenerative diseases and developmental disorders caused by defects in the Notch pathway; fusion protein |
07/24/2008 | US20080176801 Axmi-004, a delta-endotoxin gene and methods for its use |
07/24/2008 | US20080176800 Methods for the delivery of bioactive substances with biodegradable polyphosphates |
07/24/2008 | US20080176798 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
07/24/2008 | US20080176790 mutants of fibroblast growth factors containing N-linked or O-linked glycosylation sites ;drug-polymer conjugates, used for treating fibroblast growth factor deficiency in patients |
07/24/2008 | US20080176788 Apo-2 ligand |
07/24/2008 | US20080176766 Methods and compositions involving mirna and mirna inhibitor molecules |
07/24/2008 | US20080176329 Methods for Generating Hypermutable Yeast |
07/24/2008 | US20080176327 Using mutational analysis to generate cell line with optimized biochemical networks; bioinformatics |
07/24/2008 | US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases |
07/24/2008 | US20080176322 Nucleic acids and proteins of insect Or83b odorant receptor genes and uses thereof |
07/24/2008 | US20080176319 Expression vector comprising nucleotide sequences coding tumor suppressor gene (p53) for use in prevention and treatment of cell proliferative disorders |
07/24/2008 | US20080176314 Microinjection apparatus which utilizes photosensitizer to make cell, intracellular or artificial lipid membranes porous; transformation; genetic engineering |
07/24/2008 | US20080176313 Multiply-substituted protease variants |
07/24/2008 | US20080176312 Using immunoaffinity chromatography to isolate blood coagulation factor; treatment of myeloproliferative and thrombotic disorders |
07/24/2008 | US20080176310 Carbonic anhydrase for use diagnostic/prognostic tool in detectingf cell proliferative disorders of breast |
07/24/2008 | US20080176307 Using laser device to strip unnecessary material from specimen lying on substrate, place substrate on cylinder, expose cylinder to stripping agent, recover cellular material from stripping agent; tissue sectioning |
07/24/2008 | US20080176304 Designer Organisms for photosynthetic production of ethanol from carbon dioxide and water |
07/24/2008 | US20080176302 Process for the biological production of 1,3-propanediol with high yield |
07/24/2008 | US20080176297 Gene Rcs 21 |
07/24/2008 | US20080176296 Expression vector comprising nucleotide sequences coding mutants of glucose-6-phosphate dehydrogenase for transforming cells and fermenting lysine for use in medicine, nutraceutical and enhancing animal feeds |
07/24/2008 | US20080176295 Using expression vector comprising elongation factor -ts regulatory sequences as tool for transfer of heterologous gene sequences into host cells; improving exogenous gene transcription |
07/24/2008 | US20080176288 Colony stimulating factor fusion protein comprising polyanionic polymer for use tool to enhance drug delivery |
07/24/2008 | US20080176286 Method for making monoclonal antibodies and cross-reactive antibodies obtainanble by the method |
07/24/2008 | US20080176285 N-acetyl glucosamine phosphotransferase for use in treatment and prevention of lysosomal storage diseases |
07/24/2008 | US20080176284 Site specific incorporation of keto amino acids into proteins |
07/24/2008 | US20080176283 Thermotoga neapolitana DSM 5068 alkaline phosphatase (PhoA) gene and recombinant enzyme production |
07/24/2008 | US20080176282 Nucleotide sequences coding cellulase for use in textile treatment, cleaning products and production of ethanol |
07/24/2008 | US20080176280 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
07/24/2008 | US20080176279 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
07/24/2008 | US20080176277 Expanding the eukaryotic genetic code |
07/24/2008 | US20080176258 Using Carbonic anhydrase expression in breast tissues as diagnostic indicator of cell proliferative disorders |
07/24/2008 | US20080176248 Phage display affinity and specificity filters and forward screen |
07/24/2008 | US20080176247 Trimeric collagen scaffold antibodies |
07/24/2008 | US20080176244 Using virD2-interacting protein expression as diagnostic indicator of a cells competence for receiving exogenous vectors |
07/24/2008 | US20080176238 Plant farnesyltransferases |
07/24/2008 | US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
07/24/2008 | US20080176225 Membrane bound reporter gene system |
07/24/2008 | US20080175971 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
07/24/2008 | US20080175876 Novel Chitinase and Uses Thereof |
07/24/2008 | US20080175869 Mycobacterial sulfation pathway proteins and methods of use thereof |
07/24/2008 | US20080175867 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease |
07/24/2008 | US20080175866 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms |
07/24/2008 | US20080175863 immunogens and vaccines comprising myxovirus proteins having amino acid replacements; genetic engineering |
07/24/2008 | US20080175862 Recombinant Flavivirus Vaccines |
07/24/2008 | US20080175859 Recombinant infectious laryngotracheitis virus and uses thereof |
07/24/2008 | US20080175856 Enterococcus Antigens |
07/24/2008 | US20080175854 Point mutations; antibodies; fusion proteins |
07/24/2008 | US20080175843 Nucleotide sequences coding osteoblast activating factor (OAF) for use in diagnosis, prevention and treatment of inflammatory, periodontal and infectious diseases |
07/24/2008 | US20080175842 Compositions and methods for treatment |
07/24/2008 | US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies |
07/24/2008 | US20080175840 Methods for treating angiogenesis related disorders |
07/24/2008 | US20080175834 Carboxypertidase U (Cpu) Mutants |
07/24/2008 | US20080175832 Materials and Methods for Prevention and Treatment of RNA Viral Diseases |
07/24/2008 | US20080175827 Treating reproductive disorders via enhancing hydrolase expression; tissue engineering; in vitro fertilization |
07/24/2008 | US20080175819 Vector system |
07/24/2008 | US20080175818 Using replication-defective plasmid comprising p53 nucleotide sequences as as delivery tool for antitumor agents |
07/24/2008 | US20080175797 Preventing airway mucus production by administration of egf-r antagonists |